The ataxia telangiectasia-mutated (ATM) gene has been implicated as an early barrier to the growth and progression of incipient solid tumors. Here, we show that germ-line nullizygosity for the mouse Atm gene significantly increases the proliferative index, net growth rate and multiplicity of intestinal adenomas in two distinct models of familial colon cancer: Apc Min/ þ and Apc 1638N/ þ . These effects of Atm deficiency are quantitatively different from deficiency for either of the genomic stability genes Bloom's syndrome helicase or DNA ligase 4, and the effect of Atm loss on tumor multiplicity is largely independent of the effect of ionizing radiation. Furthermore, the loss of heterozygosity rates at the adenomatous polyposis coli (Apc) locus are unaffected by Atm loss. Taken together, these data implicate the Atm gene product as a barrier to dysplastic growth in the early stages of intestinal tumor progression, independent of its effects on genomic stability.
Action of the ataxia telangiectasia-mutated (ATM) gene product is highly pleiotropic; its loss of function is associated with a wide range of neurological and aging phenotypes, including a strong predisposition to lymphoid malignancies (Savitsky et al., 1995) . Recently, it has been discovered that the Atm pathway suppresses the progression of various solid tumors by triggering DNA damage response mechanisms, including senescence (Bartkova et al., 2005; Gorgoulis et al., 2005; Bartkova et al., 2006) . Atm-deficient mice rapidly develop aggressive thymic lymphomas (Barlow et al., 1996) , but have not yet shown a predisposition to epithelial neoplasia. We have therefore sought to test these aspects of Atm function using mouse models for epithelial cancer. The intestine provides a powerful experimental platform to ask whether Atm deficiency affects the formation and progression of solid tumors on adenomatous polyposis coli (Apc)-mutant backgrounds.
Apc
Min/ þ mice-which have a stop codon at position 850-develop multiple tumors throughout the intestinal tract, and are widely used to test for the effects of various mutations and environmental factors on tumorigenesis (Taketo, 2006) ; Apc 1638N/ þ -which truncates Apc at codon 1638 and decreases protein levels to B2% (Fodde et al., 1994) -is an independent model that develops 1-2 intestinal tumors with biological and molecular characteristics different from those of Apc Min/ þ tumors (Haigis et al., 2004) . We compare the results of crosses of Apc-mutant mice to Atm-deficient mice with similar crosses to mice deficient in the genomic stability proteins Bloom's syndrome helicase (Blm) or DNA ligase (Lig4).
We introgressed a null Atm allele (Barlow et al., 1996) onto the C57BL/6J (B6) background before crossing it to B6.Apc þ /À mice. Atm À/À animals on both the B6 and 129/S6 (129) backgrounds showed a significant reduction in body mass, accompanied by a consistent shortening of the small intestinal tract by an average of 3 cm (data not shown). B6.Atm À/À mice are also infertile and developed thymic lymphomas at a reduced rate (10 of 44, 23%) compared to age-matched 129.Atm À/À animals (9 of 14, 63%; Po0.05, Fisher's exact test). However, the lymphoma phenotype did not correlate with any intestinal phenotypes in Apc þ /À derivatives of these Atm À/À genotypes. To generate the three possible Atm genotypes on an Apc-mutant background, we intercrossed B6.Atm
Min/ þ background developed twofold more intestinal tumors than heterozygous Atm or wild-type age-matched controls (Table 1a) . To normalize for the length of the intestinal tract, tumors/cm 2 were measured and also found to be significantly different:
, 0.970.1 (Po0.01, Kruskal-Wallis test). Atm deficiency also produced a significant increase in colon tumor multiplicity and incidence. Notably, Atm þ /À heterozygotes did not differ significantly from Atm þ / þ homozygous wild-type mice for tumor multiplicity in the small intestine (P>0.1) or colon (P>0.2) or for incidence of colonic tumors (P>0.6). However, the average tumor diameter at 100-109 days of age increased significantly with decreasing allelic dosage of wild-type Atm (Figure 1 ). The increase in size was uniform throughout the length of the intestine, with each quartile of the small intestine demonstrating a significant difference (Po0.02, Jonckheere-Terpstra test; data not shown). Preliminary data from four mice indicate that this size increase also holds true at 160-168 days of age (data not shown). We investigated whether the increase in tumor size reflected an enhancement of cellular proliferation. ) were negative or only weakly positive for nuclear b-catenin, despite the loss of detectable Apc antigen (Figure 2 , compare m-r to g-l). We controlled for differences in staining by processing Apc
Min/ þ and Apc 1638N/ þ tumor sections in parallel. A similar result has been reported elsewhere (Janssen et al., 2006) , but it remains unclear by what alternative mechanism Apc 1638N/ þ tumors initiate. Next, we found that nullizygosity for Atm dramatically increased the multiplicity of Apc 1638N/ þ tumors in the small intestine, by 16-fold (Table 1a) . Atm heterozygotes did not differ from Atm wild-type mice in the multiplicity of Apc 1638N/ þ tumors in the small intestine +/À mice were a gift from Frederick Alt (Harvard University, Boston, MA, USA). All mice were backcrossed to B6 for at least 11 (Atm), 10 (Blm) or 5 (Lig4) generations. Mouse husbandry and dissection were performed as previously described (Haigis et al., 2002) . All mice were dissected between 3 and 5 months of age except for irradiated mice, which became moribund at 2 months. Whole-body IR was delivered using a Mark I 137 Cs irradiator, model 30 (JL Shepard & Assoc., San Fernando, CA, USA), as previously described (Luongo and Dove, 1996 (P>0.7). Colonic tumor multiplicity and incidence were also significantly increased by Atm deficiency, as both Atm þ /À heterozygous and Atm þ / þ wild-type control groups of Apc 1638N/ þ developed no colonic tumors, while 45% of Atm À/À derivatives developed at least one. These colonic tumors showed a histological appearance indistinguishable from those of Apc Min/ þ animals. The low overall tumor multiplicity in controls precluded a rigorous statistical analysis of tumor size. Overall, these results indicate that loss of Atm function enhances intestinal tumorigenesis, regardless of the initial underlying molecular mechanism. Because the functions of Atm encompass more than cellular growth, we tested the effects of Atm loss on 
and (p-r) Atm À/À ; Apc 1638N/ þ tumors stained for b-catenin (red), Apc (green) and H&E. Histological classification was determined using Apc levels and cellular morphology. Immunofluorescence was performed as described previously (Haigis et al., 2002) , 45 of 51 (88%), ruling out a strong effect of Atm loss on this mechanism of tumor initiation. Second, we measured the regional localization of intestinal tumors, which is hypothesized to correlate with the mechanism of induction (Haigis et al., 2004) . Atm deficiency did not affect the regional distribution of tumors per 10 or 25% subinterval of the small intestine, for either Apc Min/ þ or Apc 1638N/ þ mice (data not shown). Finally, we induced DNA double-strand breaks, using whole-body ionizing radiation (IR). Unlike the acute sensitivity of 129.Atm À/À mice to IR, B6.Atm À/À mice with or without Apc mutations survived for over 2 months after a single 5 Gy dose at 10 days of age. Dissections of age-matched mice showed that after IR Atm deficiency affected the multiplicity of Apc Min/ þ -induced tumors in the colon, but not in the small intestine, compared to irradiated Atm þ / þ ; Apc Min/ þ controls (Table 1a) . However, after adjusting for intestinal length, a significant effect of Atm deficiency was seen for tumors/cm 2 in the small intestine: Atm þ / þ , 3.370.6; Atm þ /À , 3.470.5; Atm À/À 4.470.4 (Po0.05, Jonkheere-Terpstra test). Thus, Atm nullizygosity has an effect at least partially independent of the genomic instability caused by IR.
To probe further the effects of genomic stability on intestinal tumors, we contrasted Atm mutants with a mutant for the Blm gene. In agreement with other observations (Luo et al., 2000) , homozygosity for a Blm hypomorphic allele (Blm m3 ) increased Apc Min/ þ tumor multiplicity 3.8-fold (Table 1b) . Blm m3/ þ heterozygotes and homozygous wild types did not differ significantly from each other (P>0.3). No studies have yet been reported for Blm and Apc 1638N/ þ ; we found that in contrast to Atm-deficiency, Blm-deficiency had only a fivefold enhancing effect on B6.Apc 1638N/ þ tumor multiplicity (Table 1b) . Importantly, the 95% confidence interval (CI) for the fold increase caused by Blm deficiency does not overlap with the larger effect caused by Atm deficiency. Furthermore, only 1 of 20 B6.Blm m3/m3 ; Apc 1638N/ þ mice developed colonic tumors, which is not statistically different from heterozygotes or wild-type controls (P>0.4) but is significantly different from Atm
01). This Blm hypomorph is known to increase Apc
Min/ þ tumor multiplicity via an increase in somatic recombination proximal to the Apc locus (Luo et al., 2000; Goss et al., 2002) . Therefore, our results with the Blm m3 allele argue that the generation of Apc 1638N/1638N cells is not sufficient to induce adenomas at a high rate. Thus, although genome-wide somatic hyperrecombination strongly enhances Apc Min/ þ -induced tumors, it is insufficient to explain the dramatic affect of Atm loss on Apc 1638N/ þ tumorigenesis. Finally, we sought further evidence for an effect of Atm deficiency distinct from genomic instability by studying Apc-mutant mice haploinsufficient for Lig4, which encodes a protein involved in maintaining genomic stability and which, unlike some modifiers of Apc Min/ þ -Blm (Luo et al., 2000; Goss et al., 2002) , Recql4 (Mann et al., 2005) or Bub1R (Rao et al., 2005) -has no known role in cell cycle checkpoints (Frank et al., 2000) . Lig4 þ /À mice have previously been shown to increase the genomic instability and multiplicity of sarcomas in Ink4a/Arf À/À mice (Sharpless et al., 2001) . By contrast, B6.Lig4
; Apc 1638N/ þ mice did not have a significantly different tumor multiplicity (P>0.6; data not shown) or average size (P>0.9) when compared to Lig4 þ / þ controls. Taken together, these and the preceding results suggest that the effect of Atm deficiency on intestinal tumorigenesis involves functions beyond the maintenance of genomic stability.
Atm encodes a protein with pleiotropic functions involving cell cycle checkpoints, DNA double-strand break repair, senescence and apoptosis. It has recently been proposed that Atm and other checkpoint proteins also serve as barriers to the growth of incipient tumors (Bartkova et al., 2005; Gorgoulis et al., 2005) . Various human solid tumors show a sharp increase in an activated form of Atm protein at early stages, signals that are then diminished or lost in later-stage carcinomas. Other recent evidence in human tumors correlates a decrease in colon tumor-specific Atm protein levels (Grabsch et al., 2006) and an increase in Atm promoter hypermethylation (Bai et al., 2004) with progression to carcinoma and decreased survival. Allelic imbalance at the 11q22-23 interval containing Atm is also associated with polyploidy in colorectal carcinomas (Sugai et al., 2001) . Inactivation of the Atm and/or related pathways The signals were counted, with the observer blind to the genotype, from digital photomicrographs displayed on a computer screen. Only crypts that were clearly epithelial by H&E staining on adjacent serial sections were assessed. Apc staining was used to discriminate between tumor (negative staining) and non-tumor (positive staining) tissue. Cells from the poorly characterized 'cap' of Apc-positive cells surrounding the lumenal edges of tumors were not included. Six tumors and adjacent hyperplastic tissue were analysed per genotype. The P-values were calculated using Fisher's exact test.
might therefore be required for tumor progression. We have reported here that ablation of the Atm gene significantly sensitizes intestinal epithelia to both tumor multiplicity and growth. These findings, along with the recent studies of Atm knockdown in mouse cell line explants and the inverse correlation between senescence and colorectal tumor progression (Bartkova et al., 2006) lend strong support to the hypothesis that the Atm function can negatively regulate tumor emergence in epithelial tissues. Additionally, heterozygosity for the Atm mutation appeared to affect intestinal tumor size (but not multiplicity); Atm haploinsufficiency has long been controversially associated with human breast cancer (Renwick et al., 2006) . How exactly does Atm control intestinal tumor multiplicity and size via proliferation? The pleiotropy of Atm action makes this a difficult question to answer, and is further complicated by the possibility that Atm could act in a non-cell autonomous fashion, similar to studies implicating stromal p53 loss in mouse models of prostate cancer (Hill et al., 2005) . Nevertheless, models of possible pathways can be constructed. For example, p53 protein is phosphorylated directly by the Atm kinase (Westphal et al., 1997) ; perhaps perturbed p53 signaling, including decreased expression levels of p21, potentiates increased cell survival and/or proliferation.
Indeed, we have shown previously that p53 nullizygosity on the B6 background increases Apc Min/ þ tumor multiplicity from 32 to 45 tumors (Halberg et al., 2000) ; however, this is significantly less than the increase from Atm loss (Po0.05). Thus, other pathways are likely involved: for example, Atm also regulates cell cycle checkpoints, lying directly upstream of many key effectors such as Chk2 (Matsuoka et al., 2000) . In principle, defective checkpoint signaling can result in the deregulation of cell division. Finally, the increase in proliferation is consistent with a loss of senescence induction, as recently proposed for the knockdown of Atm (Bartkova et al., 2006) . Confirmation of this speculation will require analysis of senescence markers.
In summary, we have demonstrated that Atm can negatively regulate tumorigenesis in epithelial tissues by opposing the proliferation of dysplastic cells, acting independently of effects on genomic stability.
